Menu

Close

A complex containing lysine-acetylated actin inhibits the formin INF2

Mu A, Tak Shun Fung, Arminja N. Kettenbach, Rajarshi Chakrabarti, Henry Higgs

Preprint posted on December 31, 2018 https://www.biorxiv.org/content/10.1101/509133v1

CAPing INF2 activity: Identification of a cellular factor that facilitates INF2 auto-inhibition

Selected by Laura McCormick

Categories: biochemistry, cell biology

Background:

Actin filaments perform an amazingly diverse number of roles in the cell—ranging from cell division to vesicle trafficking to mitochondrial division. Underlying the distinct roles that different populations of polymerized actin can play are the myriad of proteins that regulate actin polymerization.

The formin family of proteins is united by their ability to nucleate actin filaments, overcoming the rate-limiting step of actin polymerization. In recent years, the Higgs lab has extensively studied inverted formin 2 (INF2). In addition to nucleating new actin filaments, INF2 enhances the elongation of actin filaments and accelerates actin depolymerization by severing filaments.  Among other roles in the cell, INF2 regulates actin polymerization required for ER-mitochondria calcium transport and mitochondrial division.

A subset of formin proteins are regulated through autoinhibition between the conserved Diaphanous Inhibitory Domain (DID) and the C-terminal Diaphanous Auto-regulatory Domain (DAD). While cellular assays show that regulation of INF2 activity requires the DID-DAD interaction, purified INF2 protein is constitutively active in biochemical assays. To reconcile this disparity, the Higgs lab hypothesized that cellular factor enhances INF2 autoinhibition via the DID-DAD and properly regulates INF2 activity.

Key Findings:

To identify the INF2 inhibitor, the Higgs lab utilized a classic biochemical approach. Mouse brain cytosol was run through various column chromatography steps and fractionated. Each fraction was then mixed with purified INF2 protein to evaluate INF2’s ability to polymerize actin. Fractions that inhibited INF2 activity were pooled and continued through subsequent fractionation until the final Brain Inhibitory Fraction (BIF) was purified. While the BIF inhibited full length INF2 activity, it did not inhibit an INF2 construct lacking the DID domain, suggesting the BIF enhanced INF2 inhibition through DID-DAD interactions.

When the BIF was separated on a SDS-PAGE gel, five protein bands were visualized and sent for mass spectrometry identification. Notably, cyclase associated protein 1 and 2 (CAP1, CAP2) were identified. CAP proteins can bind actin monomers and enhance polymerization, as well as bind actin filaments and enhance severing. While immunodepletion of CAP2 eliminated the strong inhibitory action of the BIF, the authors found recombinant CAP (purified from HEK293 cells) only weakly inhibited INF2 activity in vitro.

Although the differences in inhibitory activity between brain purified and recombinant CAP were puzzling, the authors hypothesized that an addition protein may enhance INF2 inhibition. As CAP binds and co-purifies with actin monomers, they questioned if brain actin vs. HEK293 actin could affect the CAP-INF2 interaction. Following actin-exchange assays, the authors confirmed that recombinant CAP bound to brain actin inhibits INF2 significantly better than CAP bound to HEK293 actin. As most in vitro actin assays utilize actin purified from rabbit or chicken skeletal muscle, the authors also tested the inhibitory action of CAP exchanged with these actin sources. While CAP-chicken actin showed inhibitory activity comparable to CAP-brain actin, CAP-rabbit actin had minimal impact on INF2. To help interpret these disparities in inhibition between actin sources, they probed post-translational modifications of chicken actin by mass spec and identified 4 acetylated residues. Deacetylation of chicken actin by Histone Deacetylase 6 (HDAC6) significantly decreased the inhibitory effect of CAP-chicken actin on INF2 activity, confirming that actin lysine acetylation is key component of CAP-mediated INF2 inhibition.

Fig. 1. TIRF microscopy of actin polymerization in vitro. While full-length INF2 (INF2-FL) alone enhances actin polymerization, the presence of CAP-actin strongly inhibits INF2 activity.

To understand the physiological role of CAP-acetylated actin inhibition and HDAC6-mediated deacetylation, the authors completed several cellular assays. Previous work in several labs, including the Higgs lab, has shown that ionomycin-induced calcium influx in cultured U2OS cells stimulates an INF2-mediated burst of actin polymerization and subsequent mitochondrial division. Interestingly, they found that treatment with Tubastatin A, an inhibitor of HDAC6, blocked the ionomycin-induced actin burst, suggesting that deacetylation of the CAP-actin complex is required for INF2 activation in cells. Supporting this hypothesis, they also found ionomycin treatment transiently decreases the amount of acetylated actin bound to CAP2, as well as the amount of INF2 co-purified with CAP. Interestingly, mutations in the INF2 DID domain have been observed in Charcot-Marie Tooth Disease and Focal Segmental Glomerulosclerosis. Cells transfected with INF2 constructs containing disease-linked mutations exhibit elevated levels of polymerized actin, suggesting these mutations increase basal INF2 activity. Furthermore, these INF2 disease constructs did not co-purify with CAP2 from U2OS cells and were weakly inhibited by CAP-actin in actin pyrene assays. Collectively, these data show that the CAP-acetylated actin complex facilitates INF2 autoinhibition and dysregulation of INF2 activity is linked to disease states.

Fig 2.  INF2 auto-inhibition is facilitated by the CAP-acetylated actin complex and is relieved by HDAC-6 mediated deacetylation of actin.

Why I Selected:

  • In this paper, the authors employed classic column chromatography—old-school biochemistry—to identify the cellular inhibitor. In the era of proximity-ligation screens such as APEX2 and BioID, reverting to such a traditional method is quite unusual. The amount of the work that went into isolating the BIF is commendable.
  • The identification of acetylated actin as a required component of the CAP inhibitory complex is surprising. This paper is the first to show a role for lysine-acetylated actin and it will be interesting to see what other cellular processes lysine-acetylated actin influences.

Questions for the Authors:

  1. How did the lab begin working on INF2?
  2. Why did you choose a classic biochemistry approach to identify the INF2 inhibitor?
  3. Do you hypothesize that other mechanisms exist for relieving INF2 facilitated-autoinhibition besides the deacetylation of actin?
  4. Interestingly, both INF2 and CAP can contribute to actin polymerization and depolymerization (through severing). Is this purely coincidental or do you think there is a connection there? On a related note, while you’ve shown that CAP-Actin inhibits INF-2 mediated actin polymerization (both nucleation and elongation), does it also inhibit filament severing?
  5. Do you think acetylated actin may have broader roles than INF2 regulation?

Tags: acetylatation, actin, cytoskeleton, formin

Posted on: 25th January 2019

Read preprint (No Ratings Yet)




  • Author's response

    Mu A and Henry Higgs shared

    1. How did the lab begin working on INF2?  

    Purely out of curiosity.  In 2004, we began working on an uncharacterized ORF in the human genome, with its only two features of interest being:  1) it had formin-homology domains, and 2) it’s domains were organized in a somewhat different manner than other formins.  We named the protein Inverted Formin 2 (INF2).  At first, we just did biochemical work on it, and found it had cool properties (severing, depolymerization).  In 2009, we found that one INF2 isoform is tightly bound to ER, which was bizarre because there was no real connection known between mammalian ER and actin, and INF2 knock-down did nothing to the ER as far as we could see.  In 2011, we were then led to mitochondria by a circuitous route, which has been very exciting.  Eventually, we wanted to know how INF2 was regulated, and found all the surprises reported here.  So, basically, we’ve taken a path deeper and deeper into the woods, being drawn in by curious features at every turn.

    2. Why did you choose a classic biochemistry approach to identify the INF2 inhibitor?

    Honestly, techniques such as APEX2 and BioID would probably not have been successful here.  In 2010, we had tried INF2 immuno-precipitation, and had identified many, many potential interacting partners, including many actin-binding proteins such as CAP.  While we thought some might be relevant (and we did pursue some), our suspicion was that they could be artifactual due to stable actin filaments in the extract.  We definitely found actin in the IPs, but would never have suspected it was regulatory.  Though activity-based purification seems a crazy way to do things, this is an approach with which Harry has long experience from his grad school days, but it takes a particular set of circumstances to pull off.  We suspected it would be a long route (and it was), with lots of false leads (and there were), and that it would take lots of determination (and it did), but Mu was definitely up to the task!  Another key factor was that Mu is a very skilled biochemist.  Without that, the project would have moved too slowly and we would have given up.    Another key was timing.  Anna Hatch started the project and showed that the INF2 inhibitory activity could fractionate as two clean peaks by gel filtration, but she was relatively far along in her thesis and we realized it was too risky for her to dive into this.  In addition, we did not have a reliable way of producing full-length INF2.  Then Mu came along and started on this early in her thesis.  In addition, there was a key technological ingredient about the time Mu started, in that a junior investigator (Jason McLellan) introduced a robust HEK293-based expression/purification system that we needed for full-length INF2.  So, it was a case of the right person at the right time with the right tools.

    3. Do you hypothesize that other mechanisms exist for relieving INF2 facilitated-autoinhibition besides the deacetylation of actin?

    That is definitely possible.  CAP-binding factors, or modifications to the CAP, the CAP-bound Ac-actin, or to INF2 itself could potentially disrupt the interaction.

    4. Interestingly, both INF2 and CAP can contribute to actin polymerization and depolymerization (through severing). Is this purely coincidental or do you think there is a connection there? On a related note, while you’ve shown that CAP-Actin inhibits INF-2 mediated actin polymerization (both nucleation and elongation), does it also inhibit filament severing? 

    INF2’s severing activity is still a mystery to us.  It is a very potent biochemical activity (much more potent than cofilin), and requires the actin filaments to “age” (by releasing the phosphate product of ATP hydrolysis).  As with any severing protein, the severing could serve two purposes:  1) to enhance overall actin polymerization, by creating more barbed ends for elongation; or 2) to enhance depolymerization, by creating more barbed ends for depolymerization!  Biochemically, we find that INF2 can depolymerize actin very rapidly, but this is under conditions that might never occur in cells (high INF2: actin ratio).  All the same, the transient nature of the INF2-mediated actin burst in cells makes it tempting to speculate that the severing/depolymerizing activity might take part in shut-off of the actin burst.  We have no proof for this, and have found it very hard to test because a key region for severing (the WH2/DAD) is also key for INF2 regulation.  We have not been able to make INF2 mutants that do not sever (but are still regulated correctly).  We are currently testing whether full-length INF2 severs (not yet proven) and whether CAP/Ac-actin regulates this.

    5. Do you think acetylated actin may have broader roles than INF2 regulation? 

    We think this is the tip of the iceberg.  We find evidence for acetylation on 10 lysines on actin, and are busy identifying the key Ac-lysines for INF2 regulation in particular.  However, we think all of the Ac-lysines are probably doing something.  With about 200 mM actin in most mammalian cells, and many actin assembly factors present at <1 mM, it is an attractive mechanism to modify a small fraction of the substrate in order to regulate activity.  Frankly, why stop with regulation of actin assembly factors?  Ac-actin could regulate other processes as well.  It is already known, for example, that actin monomers are component of chromatin remodeling complexes that have (as far as we know) little to do with actin filaments.  We’ll see!

    Have your say

    Your email address will not be published. Required fields are marked *

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    Sign up to customise the site to your preferences and to receive alerts

    Register here

    Also in the biochemistry category:

    A DNA-based voltmeter for organelles

    Anand Saminathan, John Devany, Kavya S Pillai, et al.



    Selected by Robert Mahen

    Structures of the Otopetrin Proton Channels Otop1 and Otop3

    Kei Saotome, Bochuan Teng, Che Chun (Alex) Tsui, et al.



    Selected by David Wright

    Inactive USP14 and inactive UCHL5 cause accumulation of distinct ubiquitinated proteins in mammalian cells

    Jayashree Chadchankar, Victoria Korboukh, Peter Doig, et al.



    Selected by Mila Basic

    S-acylated Golga7b stabilises DHHC5 at the plasma membrane to regulate desmosome assembly and cell adhesion.

    Keith T Woodley, Mark O Collins



    Selected by Abagael Lasseigne

    3

    Super-resolution Molecular Map of Basal Foot Reveals Novel Cilium in Airway Multiciliated Cells

    Quynh Nguyen, Zhen Liu, Rashmi Nanjundappa, et al.



    Selected by Robert Mahen

    Atlas of Subcellular RNA Localization Revealed by APEX-seq

    Furqan M Fazal, Shuo Han, Pornchai Kaewsapsak, et al.

    AND

    Proximity RNA labeling by APEX-Seq Reveals the Organization of Translation Initiation Complexes and Repressive RNA Granules

    Alejandro Padron, Shintaro Iwasaki, Nicholas Ingolia



    Selected by Christian Bates

    Applications, Promises, and Pitfalls of Deep Learning for Fluorescence Image Reconstruction

    Chinmay Belthangady , Loic A. Royer



    Selected by Romain F. Laine

    Activation of intracellular transport by relieving KIF1C autoinhibition

    Nida Siddiqui, Alice Bachmann, Alexander J Zwetsloot, et al.



    Selected by Ben Craske, Thibault Legal and Toni McHugh

    1

    Reduced mitochondrial lipid oxidation leads to fat accumulation in myosteatosis

    Jonathan P Gumucio, Austin H Qasawa, Patrick J Ferrara, et al.



    Selected by Pablo Ranea Robles

    Integrated NMR and cryo-EM atomic-resolution structure determination of a half-megadalton enzyme complex

    Diego Gauto, Leandro Estrozi, Charles Schwieters, et al.



    Selected by Reid Alderson

    1

    Disrupting Transcriptional Feedback Yields an Escape-Resistant Antiviral

    Sonali Chaturvedi, Marie Wolf, Noam Vardi, et al.



    Selected by Pavithran Ravindran

    1

    Structure of a cytochrome-based bacterial nanowire

    David J Filman, Stephen F Marino, Joy E Ward, et al.



    Selected by Amberley Stephens

    Multi-color single molecule imaging uncovers extensive heterogeneity in mRNA decoding

    Sanne Boersma, Deepak Khuperkar, Bram M.P. Verhagen, et al.

    AND

    Live-cell single RNA imaging reveals bursts of translational frameshifting

    Kenneth R Lyon Jr, Luis U Aguilera, Tatsuya Morisaki, et al.



    Selected by Nicola Stevenson

    Retrieving High-Resolution Information from Disordered 2D Crystals by Single Particle Cryo-EM

    Ricardo Righetto, Nikhil Biyani, Julia Kowal, et al.



    Selected by David Wright

    Structural venomics: evolution of a complex chemical arsenal by massive duplication and neofunctionalization of a single ancestral fold

    Sandy Steffany Pineda, Yanni K-Y Chin, Eivind A.B. Undheim, et al.



    Selected by Tessa Sinnige

    Microtubules Gate Tau Condensation to Spatially Regulate Microtubule Functions

    Ruensern Tan, Aileen J. Lam, Tracy Tan, et al.

    AND

    Kinetically distinct phases of tau on microtubules regulate kinesin motors and severing enzymes

    Valerie Siahaan, Jochen Krattenmacher, Amayra Hernandez-Vega, et al.



    Selected by Satish Bodakuntla

    2

    Also in the cell biology category:

    A DNA-based voltmeter for organelles

    Anand Saminathan, John Devany, Kavya S Pillai, et al.



    Selected by Robert Mahen

    Central spindle microtubules are strongly coupled to chromosomes during both anaphase A and anaphase B

    Che-Hang Yu, Stefanie Redemann, Hai-Yin Wu, et al.



    Selected by Federico Pelisch

    1

    Cell growth dilutes the cell cycle inhibitor Rb to trigger cell division

    Evgeny Zatulovskiy, Daniel F. Berenson, Benjamin R. Topacio, et al.



    Selected by Zaki Ahmad

    1

    Minimal membrane interactions conferred by Rheb C-terminal farnesylation are essential for mTORC1 activation

    Shawn M Ferguson, Brittany Angarola



    Selected by Sandra Malmgren Hill

    Mechanical Stretch Kills Transformed Cancer Cells

    Ajay Tijore, Mingxi Yao, Yu-Hsiu Wang, et al.



    Selected by Vibha SINGH

    EHD2-mediated restriction of caveolar dynamics regulates cellular lipid uptake

    Claudia Matthaeus, Ines Lahmann, Severine Kunz, et al.



    Selected by Andreas Müller

    1

    Mechanical Stretch Kills Transformed Cancer Cells

    Ajay Tijore, Mingxi Yao, Yu-Hsiu Wang, et al.



    Selected by Joseph Jose Thottacherry

    Inactive USP14 and inactive UCHL5 cause accumulation of distinct ubiquitinated proteins in mammalian cells

    Jayashree Chadchankar, Victoria Korboukh, Peter Doig, et al.



    Selected by Mila Basic

    A metabolic switch from OXPHOS to glycolysis is essential for cardiomyocyte proliferation in the regenerating heart

    Hessel Honkoop, Dennis de Bakker, Alla Aharonov, et al.



    Selected by Andreas van Impel

    1

    S-acylated Golga7b stabilises DHHC5 at the plasma membrane to regulate desmosome assembly and cell adhesion.

    Keith T Woodley, Mark O Collins



    Selected by Abagael Lasseigne

    3

    A complex containing lysine-acetylated actin inhibits the formin INF2

    Mu A, Tak Shun Fung, Arminja N. Kettenbach, et al.



    Selected by Laura McCormick

    1

    Super-resolution Molecular Map of Basal Foot Reveals Novel Cilium in Airway Multiciliated Cells

    Quynh Nguyen, Zhen Liu, Rashmi Nanjundappa, et al.



    Selected by Robert Mahen

    Single cell RNA-Seq reveals distinct stem cell populations that drive sensory hair cell regeneration in response to loss of Fgf and Notch signaling

    Mark E. Lush, Daniel C. Diaz, Nina Koenecke, et al.

    AND

    Distinct progenitor populations mediate regeneration in the zebrafish lateral line.

    Eric D Thomas, David Raible



    Selected by Rudra Nayan Das

    1

    Actomyosin-II facilitates long-range retrograde transport of large cargoes by controlling axonal radial contractility

    Tong Wang, Wei Li, Sally Martin, et al.



    Selected by Ivana Viktorinová

    Atlas of Subcellular RNA Localization Revealed by APEX-seq

    Furqan M Fazal, Shuo Han, Pornchai Kaewsapsak, et al.

    AND

    Proximity RNA labeling by APEX-Seq Reveals the Organization of Translation Initiation Complexes and Repressive RNA Granules

    Alejandro Padron, Shintaro Iwasaki, Nicholas Ingolia



    Selected by Christian Bates

    Applications, Promises, and Pitfalls of Deep Learning for Fluorescence Image Reconstruction

    Chinmay Belthangady , Loic A. Royer



    Selected by Romain F. Laine
    Close